These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28834165)

  • 1. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia.
    Peng HL; Zhang Y; Sun NN; Yin YF; Wang YW; Cheng Z; Yan WZ; Liu SF; Xu YX; Xiao X; Zhang GS
    J Thromb Haemost; 2017 Nov; 15(11):2259-2269. PubMed ID: 28834165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
    Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
    J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
    Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
    J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Shinya Y; Hiraide T; Momoi M; Goto S; Suzuki H; Katsumata Y; Kurebayashi Y; Endo J; Sano M; Fukuda K; Kosaki K; Kataoka M
    J Am Heart Assoc; 2021 Feb; 10(5):e019245. PubMed ID: 33586470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.
    Gu D; Ge J; Du W; Xue F; Chen Z; Zhao H; Zhou Z; Xu J; Liu P; Zhao Q; Zhang L; Yang R
    Autoimmunity; 2009; 42(8):692-8. PubMed ID: 19824872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
    Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
    Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood.
    Gözmen S; Karapnar TH; Tüfekçi Ö; Vergin C; Yüksel F; İrken G; Ören H
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):494-9. PubMed ID: 24911453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
    Salzer U; Bacchelli C; Buckridge S; Pan-Hammarström Q; Jennings S; Lougaris V; Bergbreiter A; Hagena T; Birmelin J; Plebani A; Webster AD; Peter HH; Suez D; Chapel H; McLean-Tooke A; Spickett GP; Anover-Sombke S; Ochs HD; Urschel S; Belohradsky BH; Ugrinovic S; Kumararatne DS; Lawrence TC; Holm AM; Franco JL; Schulze I; Schneider P; Gertz EM; Schäffer AA; Hammarström L; Thrasher AJ; Gaspar HB; Grimbacher B
    Blood; 2009 Feb; 113(9):1967-76. PubMed ID: 18981294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic thrombocytopenic purpura (ITP): is there a genetic predisposition?
    Rischewski JR; Imbach P; Paulussen M; Kühne T
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):678-80. PubMed ID: 16933243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
    Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
    Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
    Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocyte apoptosis in immune thrombocytopenia.
    Vrbensky JR; Nazy I; Toltl LJ; Ross C; Ivetic N; Smith JW; Kelton JG; Arnold DM
    Platelets; 2018 Nov; 29(7):729-732. PubMed ID: 29787328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
    Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
    Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura.
    Uçar C; Oren H; Irken G; Ateş H; Atabay B; Türker M; Vergin C; Yaprak I
    Eur J Haematol; 2003 Jun; 70(6):347-52. PubMed ID: 12756015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.
    Wang Y; Guo Y; Zhang X; Zhao H; Zhang B; Wu Y; Zhang J
    RNA Biol; 2021 Nov; 18(11):1953-1968. PubMed ID: 33586614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PTPN22 gene polymorphism in childhood immune thrombocytopenic purpura.
    Anis SK; Abdel Ghany EA; Mostafa NO; Ali AA
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):521-5. PubMed ID: 21597364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia.
    Chen Z; Guo Z; Ma J; Liu F; Gao C; Liu S; Wang A; Wu R
    Autoimmunity; 2015; 48(5):305-12. PubMed ID: 25707685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased let-7b-5p is associated with enhanced BAFF-R expression and B cell survival in immune thrombocytopenia.
    Wang Y; Jia X; Zhou L; Yin J; Zhao Y; Dai L; Zuo B; He Y
    Int Immunopharmacol; 2021 Apr; 93():107393. PubMed ID: 33529914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.